UniProt ID | TR10A_HUMAN | |
---|---|---|
UniProt AC | O00220 | |
Protein Name | Tumor necrosis factor receptor superfamily member 10A | |
Gene Name | TNFRSF10A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 468 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | Receptor for the cytotoxic ligand TNFSF10/TRAIL. [PubMed: 26457518 The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B.] | |
Protein Sequence | MAPPPARVHLGAFLAVTPNPGSAASGTEAAAATPSKVWGSSAGRIEPRGGGRGALPTSMGQHGPSARARAGRAPGPRPAREASPRLRVHKTFKFVVVGVLLQVVPSSAATIKLHDQSIGTQQWEHSPLGELCPPGSHRSEHPGACNRCTEGVGYTNASNNLFACLPCTACKSDEEERSPCTTTRNTACQCKPGTFRNDNSAEMCRKCSRGCPRGMVKVKDCTPWSDIECVHKESGNGHNIWVILVVTLVVPLLLVAVLIVCCCIGSGCGGDPKCMDRVCFWRLGLLRGPGAEDNAHNEILSNADSLSTFVSEQQMESQEPADLTGVTVQSPGEAQCLLGPAEAEGSQRRRLLVPANGADPTETLMLFFDKFANIVPFDSWDQLMRQLDLTKNEIDVVRAGTAGPGDALYAMLMKWVNKTGRNASIHTLLDALERMEERHAREKIQDLLVDSGKFIYLEDGTGSAVSLE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
36 | Ubiquitination | AAAATPSKVWGSSAG CCCCCCCHHCCCCCC | 43.12 | 21906983 | |
52 | Methylation | IEPRGGGRGALPTSM CCCCCCCCCCCCCCC | 30.41 | 24129315 | |
57 | O-linked_Glycosylation | GGRGALPTSMGQHGP CCCCCCCCCCCCCCH | 31.99 | OGP | |
83 | Phosphorylation | PRPAREASPRLRVHK CCCCCCCCCCCCCCC | 13.05 | 22817900 | |
126 | O-linked_Glycosylation | GTQQWEHSPLGELCP CCCCCCCCCCCCCCC | 15.42 | OGP | |
156 | N-linked_Glycosylation | TEGVGYTNASNNLFA CCCCCCCCCCCCEEE | 32.65 | UniProtKB CARBOHYD | |
178 | Phosphorylation | KSDEEERSPCTTTRN CCCHHHCCCCCCCCC | 27.83 | 25159151 | |
191 | Ubiquitination | RNTACQCKPGTFRND CCCCCCCCCCCCCCC | 22.17 | 21963094 | |
217 | Ubiquitination | GCPRGMVKVKDCTPW CCCCCCEECCCCCCH | 34.37 | 27667366 | |
219 | Ubiquitination | PRGMVKVKDCTPWSD CCCCEECCCCCCHHH | 41.17 | 29967540 | |
261 | S-palmitoylation | LVAVLIVCCCIGSGC HHHHHHHHHHHCCCC | 0.93 | 19090789 | |
262 | S-palmitoylation | VAVLIVCCCIGSGCG HHHHHHHHHHCCCCC | 1.00 | 19090789 | |
263 | S-palmitoylation | AVLIVCCCIGSGCGG HHHHHHHHHCCCCCC | 3.14 | 19090789 | |
273 | Ubiquitination | SGCGGDPKCMDRVCF CCCCCCHHHHHHHHH | 47.10 | - | |
336 | S-nitrosylation | QSPGEAQCLLGPAEA CCCCCEEEEECCCCC | 4.34 | 22178444 | |
336 | S-nitrosocysteine | QSPGEAQCLLGPAEA CCCCCEEEEECCCCC | 4.34 | - | |
379 | Phosphorylation | ANIVPFDSWDQLMRQ CCCCCCCCHHHHHHH | 32.69 | 22210691 | |
390 | Phosphorylation | LMRQLDLTKNEIDVV HHHHHCCCCCCCCEE | 31.33 | 22210691 | |
391 | Ubiquitination | MRQLDLTKNEIDVVR HHHHCCCCCCCCEEE | 60.94 | 21906983 | |
424 | Phosphorylation | NKTGRNASIHTLLDA HHHCCCCHHHHHHHH | 20.60 | 22617229 | |
424 | O-linked_Glycosylation | NKTGRNASIHTLLDA HHHCCCCHHHHHHHH | 20.60 | 30987996 | |
427 | Phosphorylation | GRNASIHTLLDALER CCCCHHHHHHHHHHH | 27.61 | 20873877 | |
443 | Ubiquitination | EERHAREKIQDLLVD HHHHHHHHHHHHHHH | 39.86 | 21906983 | |
453 | Ubiquitination | DLLVDSGKFIYLEDG HHHHHCCCEEEEECC | 32.32 | 29967540 | |
456 | Phosphorylation | VDSGKFIYLEDGTGS HHCCCEEEEECCCCC | 13.74 | 25884760 | |
461 | Phosphorylation | FIYLEDGTGSAVSLE EEEEECCCCCCEECC | 40.04 | 28176443 | |
463 | Phosphorylation | YLEDGTGSAVSLE-- EEECCCCCCEECC-- | 25.90 | 26503892 | |
466 | Phosphorylation | DGTGSAVSLE----- CCCCCCEECC----- | 26.88 | 26503892 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TR10A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TR10A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
D04858 | Mapatumumab (USAN/INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-463 AND SER-466,AND MASS SPECTROMETRY. |